BRII-732

N/A

Report date: 2025/04/17 13:40:14

Base Information

Drug NameBRII-732
Drug Alias NameBRII-732BRII 732
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitorsNucleoside reverse transcriptase translocation inhibitor
TargetsHuman immunodeficiency virus type 1 reverse transcriptaseNucleotide reverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBrii Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBrii Biosciences Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A